Clinical trial
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma…
NCT00003163 · Medical College of Wisconsin, Other · Unknown status
Key facts
| NCT number | NCT00003163 |
|---|---|
| Title | Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers |
| Official title | Myeloblative Therapy With Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma and B-Cell Malignancies |
| Lead sponsor | Medical College of Wisconsin, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, sargramostim, cyclophosphamide, melphalan, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 10 |
| Start date | Sep 1, 1997 |
| First posted | Apr 18, 2003 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: